Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.38 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 11.67% to 0.38 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.38 through Dec 2025, up 11.67% year-over-year, with the annual reading at 0.43 for FY2025, 21.18% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.38 at Rhythm Pharmaceuticals, down from 0.4 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.41 in Q2 2025, with the low at 0.0 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.17, with a median of 0.11 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio surged 13592.57% in 2022, then rose 11.67% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.01 in 2021, then surged by 91.38% to 0.02 in 2022, then surged by 1179.79% to 0.23 in 2023, then surged by 52.74% to 0.34 in 2024, then rose by 11.67% to 0.38 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.38, 0.4, and 0.41 for Q4 2025, Q3 2025, and Q2 2025 respectively.